Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    The Hospira Inc logo features a stylized medical symbol with a prominent blue feather design representing healthcare and

    Hospira Inc.

    Hospira Inc., now a subsidiary of Pfizer, is a global leader in injectable drugs, infusion technologies, and biosimilars, serving hospitals and healthcare providers worldwide.

    Company Overview

    Hospira Inc. specializes in the development, manufacturing, and distribution of sterile injectable pharmaceuticals, infusion technologies, and biosimilars. As part of Pfizer’s Global Established Pharmaceutical (GEP) business, Hospira supports hospitals and healthcare systems with a robust portfolio of generic and branded products. The company operates in the biopharmaceutical industry, focusing on acute care and medication management solutions.

    Key Metrics

    1,200

    Import Shipments

    8

    Distribution Centers

    4.0B

    Annual Revenue

    2004

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Hospira has focused on expanding its biosimilars portfolio, optimizing sterile injectable manufacturing, and integrating advanced medication management systems to meet evolving healthcare demands.

    Strategic Expansion

    Expansion of biosimilars offerings for oncology and chronic diseases

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Hospira Inc. is recognized as the world’s leading provider of injectable drugs and infusion technologies, with a significant presence in biosimilars. The company’s portfolio includes acute care and oncology injectables, anti-infectives, anti-inflammatories, and cytotoxics, as well as advanced medication management systems. Hospira’s products are distributed globally, leveraging Pfizer’s commercial capabilities and manufacturing scale. The company’s operations are designed to improve clinical care accuracy and productivity for healthcare providers.

    Headquarters

    Lake Forest, Illinois, USA

    Founded

    2004

    Stock Symbol

    Private company